Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3062-3070

  Prado, Carolina ^a,b   Contreras, Francisco ^a,b   González, Hugo ^a,b   Díaz, Pablo ^a   Elgueta, Daniela ^a   Barrientos, Magaly ^a   Herrada, Andrés A ^a   Lladser, Álvaro ^a   Bernales, Sebastián ^a   Pacheco, Rodrigo ^a,c  

^a Fundacion Ciencia para la Vida   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DOPAMINE; DOPAMINE 5 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 23;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL SURFACE; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; DOPAMINE METABOLISM; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; AUTOCRINE COMMUNICATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DOPAMINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, CELLULAR; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, DOPAMINE D5; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; TH17 CELLS;

EID: 84859415905     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103096     Document Type: Article

References (52)

1. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266. (Pubitemid 32772609)
2. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562. (Pubitemid 38680433)
3. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
4. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453. (Pubitemid 351467042)
5. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811. (Pubitemid 30365397)
6. Bhat, R., R. Axtell, A. Mitra, M. Miranda, C. Lock, R. W. Tsien, and L. Steinman. 2010. Inhibitory role for GABA in autoimmune inflammation. Proc. Natl. Acad. Sci. USA 107: 2580-2585.
7. Pacheco, R., F. Ciruela, V. Casadó, J. Mallol, T. Gallart, C. Lluis, and R. Franco. 2004. Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J. Biol. Chem. 279: 33352-33358. (Pubitemid 39062983)
8. Pacheco, R., H. Oliva, J. M. Martinez-Navío, N. Climent, F. Ciruela, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco. 2006. Glutamate released by dendritic cells as a novel modulator of T cell activation. J. Immunol. 177: 6695-6704. (Pubitemid 44715033)
9. León-Ponte, M., G. P. Ahern, and P. J. O'Connell. 2007. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109: 3139-3146. (Pubitemid 46572497)
10. O'Connell, P. J., X. Wang, M. Leon-Ponte, C. Griffiths, S. C. Pingle, and G. P. Ahern. 2006. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107: 1010-1017. (Pubitemid 43156299)
11. Grebe, K. M., H. D. Hickman, K. R. Irvine, K. Takeda, J. R. Bennink, and J. W. Yewdell. 2009. Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc. Natl. Acad. Sci. USA 106: 5300-5305.
12. Haskó, G., and C. Szabó. 1998. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem. Pharmacol. 56: 1079-1087. (Pubitemid 28511228)
13. Weihe, E., D. Nohr, S. Michel, S. Müller, H. J. Zentel, T. Fink, and J. Krekel. 1991. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59: 1-23.
14. Missale, C., S. R. Nash, S. W. Robinson, M. Jaber, and M. G. Caron. 1998. Dopamine receptors: from structure to function. Physiol. Rev. 78: 189-225. (Pubitemid 28070979)
15. Weihe, E., C. Depboylu, B. Schü tz, M. K. Schäfer, and L. E. Eiden. 2006. Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell. Mol. Neurobiol. 26: 659-678.
16. Torres, G. E., R. R. Gainetdinov, and M. G. Caron. 2003. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4: 13-25. (Pubitemid 37271085)
17. Mignini, F., D. Tomassoni, E. Traini, and F. Amenta. 2009. Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen. J. Neuroimmunol. 206: 5-13.
18. Mignini, F., E. Traini, D. Tomassoni, and F. Amenta. 2006. Dopamine plasma membrane transporter (DAT) in rat thymus and spleen: an immunochemical and immunohistochemical study. Auton. Autacoid Pharmacol. 26: 183-189.
19. Alaniz, R. C., S. A. Thomas, M. Perez-Melgosa, K. Mueller, A. G. Farr, R. D. Palmiter, and C. B. Wilson. 1999. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc. Natl. Acad. Sci. USA 96: 2274-2278. (Pubitemid 29117904)
20. Sibley, D. R., F. J. Monsma, Jr., and Y. Shen. 1993. Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35: 391-415.
21. Strange, P. G. 1993. New insights into dopamine receptors in the central nervous system. Neurochem. Int. 22: 223-236.
22. Cosentino, M., R. Bombelli, M. Ferrari, F. Marino, E. Rasini, G. J. Maestroni, A. Conti, M. Boveri, S. Lecchini, and G. Frigo. 2000. HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci. 68: 283-295.
23. Cosentino, M., A. M. Fietta, M. Ferrari, E. Rasini, R. Bombelli, E. Carcano, F. Saporiti, F. Meloni, F. Marino, and S. Lecchini. 2007. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 109: 632-642. (Pubitemid 46105964)
24. Nakano, K., T. Higashi, K. Hashimoto, R. Takagi, Y. Tanaka, and S. Matsushita. 2008. Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem. Biophys. Res. Commun. 373: 286-291.
25. Nakano, K., T. Higashi, R. Takagi, K. Hashimoto, Y. Tanaka, and S. Matsushita. 2009. Dopamine released by dendritic cells polarizes Th2 differentiation. Int. Immunol. 21: 645-654.
26. Millan, M. J., A. Newman-Tancredi, Y. Quentric, and D. Cussac. 2001. The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology (Berl.) 156: 58-62. (Pubitemid 32646325)
27. Briggs, C. A., N. J. Pollock, D. E. Frail, C. L. Paxson, R. F. Rakowski, C. H. Kang, and J. W. Kebabian. 1991. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br. J. Pharmacol. 104: 1038-1044.
28. Müller, T., T. Dürk, B. Blumenthal, M. Grimm, S. Cicko, E. Panther, S. Sorichter, Y. Herouy, F. Di Virgilio, D. Ferrari, et al. 2009. 5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS ONE 4: e6453.
29. Giorelli, M., P. Livrea, and M. Trojano. 2005. Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta. J. Interferon Cytokine Res. 25: 395-406. (Pubitemid 41026261)
30. Bałkowiec-Iskra, E., I. Kurkowska-Jastrzebska, I. Joniec, A. Ciesielska, A. Członkowska, and A. Członkowski. 2007. Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration. Acta Neurobiol. Exp. (Warsz.) 67: 379-388.
31. Hollon, T. R., M. J. Bek, J. E. Lachowicz, M. A. Ariano, E. Mezey, R. Ramachandran, S. R. Wersinger, P. Soares-da-Silva, Z. F. Liu, A. Grinberg, et al. 2002. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J. Neurosci. 22: 10801-10810. (Pubitemid 36005154)
32. Ureta, G., F. Osorio, J. Morales, M. Rosemblatt, M. R. Bono, and J. A. Fierro. 2007. Generation of dendritic cells with regulatory properties. Transplant. Proc. 39: 633-637. (Pubitemid 46574813)
33. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
34. Uemura, Y., M. Suzuki, T. Y. Liu, Y. Narita, S. Hirata, H. Ohyama, O. Ishihara, and S. Matsushita. 2008. Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy. Int. Immunol. 20: 405-412. (Pubitemid 351321248)
35. González, P. A., C. E. Prado, E. D. Leiva, L. J. Carreño, S. M. Bueno, C. A. Riedel, and A. M. Kalergis. 2008. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc. Natl. Acad. Sci. USA 105: 14999-15004.
36. Mäkelä, S. M., M. Strengell, T. E. Pietilä, P. Osterlund, and I. Julkunen. 2009. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J. Leukoc. Biol. 85: 664-672.
37. Pacheco, R., C. E. Prado, M. J. Barrientos, and S. Bernales. 2009. Role of dopamine in the physiology of T-cells and dendritic cells. J. Neuroimmunol. 216: 8-19.
38. Kawashima, K., and T. Fujii. 2003. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 74: 675-696. (Pubitemid 37494897)
39. Kawashima, K., T. Fujii, Y. Watanabe, and H. Misawa. 1998. Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes. Life Sci. 62: 1701-1705. (Pubitemid 28210265)
40. Franco, R., R. Pacheco, C. Lluis, G. P. Ahern, and P. J. O'Connell. 2007. The emergence of neurotransmitters as immune modulators. Trends Immunol. 28: 400-407. (Pubitemid 47385376)
41. Larsen, M. B., M. S. Sonders, O. V. Mortensen, G. A. Larson, N. R. Zahniser, and S. G. Amara. 2011. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation. J. Neurosci. 31: 6605-6615.
42. Metzger, R. R., J. M. Brown, V. Sandoval, K. S. Rau, M. A. Elwan, G. W. Miller, G. R. Hanson, and A. E. Fleckenstein. 2002. Inhibitory effect of reserpine on dopamine transporter function. Eur. J. Pharmacol. 456: 39-43. (Pubitemid 35351734)
43. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
44. Bourne, J. A. 2001. SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev. 7: 399-414. (Pubitemid 34263874)
45. Murphy, A. C., S. J. Lalor, M. A. Lynch, and K. H. Mills. 2010. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 24: 641-651.
46. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
47. Pacheco, R., E. Riquelme, and A. M. Kalergis. 2010. Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent. Nerv. Syst. Agents Med. Chem. 10: 65-83.
48. Besser, M. J., Y. Ganor, and M. Levite. 2005. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J. Neuroimmunol. 169: 161-171. (Pubitemid 41528789)
49. Watanabe, Y., T. Nakayama, D. Nagakubo, K. Hieshima, Z. Jin, F. Katou, K. Hashimoto, and O. Yoshie. 2006. Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J. Immunol. 176: 848-856. (Pubitemid 43099681)
50. McKenna, F., P. J. McLaughlin, B. J. Lewis, G. C. Sibbring, J. A. Cummerson, D. Bowen-Jones, and R. J. Moots. 2002. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J. Neuroimmunol. 132: 34-40. (Pubitemid 35333323)
51. Meredith, E. J., M. J. Holder, A. Rosén, A. D. Lee, M. J. Dyer, N. M. Barnes, and J. Gordon. 2006. Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma. Proc. Natl. Acad. Sci. USA 103: 13485-13490. (Pubitemid 44380134)
52. Kipnis, J., M. Cardon, H. Avidan, G. M. Lewitus, S. Mordechay, A. Rolls, Y. Shani, and M. Schwartz. 2004. Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. J. Neurosci. 24: 6133-6143. (Pubitemid 38891104)